AGM
MIRM icon

Alpine Global Management’s Mirum Pharmaceuticals MIRM Stock Holding History

Alpine Global Management’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-14,417
Closed -$493K – 328
2024
Q2 		$493K Buy
+14,417
New +$378K 0.09% 180

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Alpine Global Management's MIRM Position: Q3 2024 in Review

Alpine Global Management sold out of Mirum Pharmaceuticals (MIRM) in Q3 2024, closing a stake of 14,417 shares — an estimated $493K sold.

Alpine Global Management first reported a position in MIRM in Q2 2024 and held it in 1 quarter. The position peaked at $493K in Q2 2024. 178 funds tracked by Wall St. Rank hold MIRM as of Q3 2024.

  • Alpine Global Management reported no remaining Mirum Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
  • Alpine Global Management sold 14,417 Mirum Pharmaceuticals shares in Q3 2024, an estimated $493K.
  • Alpine Global Management first reported a position in Mirum Pharmaceuticals in Q2 2024 and held it in 1 quarter.
  • Alpine Global Management's Mirum Pharmaceuticals position peaked at $493K in Q2 2024.
  • 178 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q3 2024.

Based on Alpine Global Management's 13F filing for Q3 2024, filed 14 Nov 2024.